End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta.
Saved in:
| Title: | End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta. |
|---|---|
| Authors: | Lu, Evelyn R.1,2 (AUTHOR), Hoo, Calvin P. L.1,2 (AUTHOR), Cheung, Ho Ming3 (AUTHOR), Wong, I. W. C.3,4 (AUTHOR), Fung, K. F. Kevin4,5 (AUTHOR), Chang, Sylvia L. Y.1 (AUTHOR), Lee, Anselm C. W.1,2 (AUTHOR), Fu, Eric C. H.1,3 (AUTHOR), Ku, Dennis T. L.1,4 (AUTHOR), Yau, Jeffrey P. W.1,5 (AUTHOR), Shing, Matthew M. K.1 (AUTHOR), Mak, Christy Y. K.1 (AUTHOR), Liu, Anthony P. Y.1,5 (AUTHOR), Chan, Godfrey C. F.1 (AUTHOR) gcfchan@hku.hk |
| Source: | Cancers. Mar2026, Vol. 18 Issue 6, p1028. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
